Stock listing

NASDAQ:NVNO enVVeno Medical Corporation Stock

Home listing (NASDAQ) of enVVeno Medical Corporation

Follow enVVeno Medical Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:NVNO

$5.25 USD -0.52 (-9.0%)

Close on Nov 20, 2026

Past year -53.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$5.22 – $5.76 USDNov 20, 2026
Volume
10,355 sharesNov 20, 2026
Market cap
$3.65M USDAt the close on Nov 20, 2026 · price × 694,826 shares outstanding
52-week range
$5.22 – $14.67 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$247,262 USDMedian day 19,183 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
enVVeno Medical Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NVNO · Home$5.25 USD-0.52 (-9.0%)10,355$5.53$5.76$5.22$5.77Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NVNO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.25-0.52-9.0%$5.53$5.76$5.2210,355
$5.770.000.0%$5.77$6.30$5.5318,048
$5.77-0.175-2.9%$6.037$6.19$5.69511,056
$5.945-0.225-3.6%$6.50$6.50$5.8012,092
$6.17-0.405-6.2%$6.63$6.63$6.147,516
$6.575+0.055+0.8%$6.42$6.575$6.4144,235
$6.52+0.07+1.1%$6.96$7.562$6.455,827
$6.45-0.40-5.8%$6.80$6.80$6.36510,958
$6.85+0.12+1.8%$6.73$7.17$6.6214,977
$6.73-0.24-3.4%$7.04$7.214$6.3126,747
$6.97-0.03-0.4%$7.23$7.37$6.7922,346
$7.001-0.175-2.4%$7.17$7.741$6.99563,619
$7.175+0.305+4.4%$7.15$7.61$6.91106,309
$6.87+0.14+2.1%$6.78$7.26$6.7857,414
$6.73-0.29-4.1%$6.87$7.11$6.7019,183
$7.02+0.275+4.1%$6.89$7.34$6.87214,438
$6.745+0.005+0.1%$7.195$7.195$6.71545,302
$6.74+0.03+0.4%$6.75$6.96$6.6169,569
$6.71+0.06+0.9%$6.57$6.725$6.563,773
$6.65-0.26-3.8%$6.72$6.76$6.557,900
$6.91-0.42-5.7%$7.30$7.57$6.60130,100
$7.33-0.37-4.8%$8.27$8.27$7.2045,700
$7.70+0.01+0.1%$8.45$8.45$7.52104,200
$7.69+0.22+2.9%$7.995$8.155$7.52533,200
$7.47-0.455-5.7%$8.01$8.01$7.3067,600
$7.925+0.525+7.1%$7.27$7.925$7.2741,800
$7.40-0.57-7.2%$8.00$8.13$7.1818,900
$7.97-0.18-2.2%$8.65$8.65$7.6048,600
$8.15-0.60-6.9%$8.80$8.80$8.06122,900
$8.75+0.575+7.0%$8.41$9.58$8.4136,500
$8.175-0.225-2.7%$8.41$8.475$8.066,700
$8.40+0.20+2.4%$7.98$8.43$7.9115,100
$8.20+0.19+2.4%$8.01$8.47$7.9636,800
$8.01-0.09-1.1%$7.92$8.60$7.7510,600
$8.10+0.06+0.7%$8.11$8.78$7.7024,300
$8.04+0.24+3.1%$8.82$9.41$8.0125,200
$7.80-0.825-9.6%$8.53$9.00$7.80122,400
$8.625-0.185-2.1%$8.74$8.74$8.6242,100
$8.81+0.14+1.6%$8.81$8.81$8.811,000
$8.67-0.42-4.6%$8.67$8.67$8.67400
$9.09+0.13+1.5%$8.61$9.09$8.61700
$8.96-0.14-1.5%$8.845$8.96$8.664,500
$9.10+0.05+0.6%$8.91$9.11$8.8610,000
$9.05+0.075+0.8%$8.84$9.157$8.5925,100
$8.975+0.182+2.1%$8.95$9.155$8.6457,900
$8.793-0.257-2.8%$9.19$9.44$8.784,500
$9.05-0.27-2.9%$9.416$9.44$7.0139,300
$9.32-0.06-0.6%$9.60$9.60$9.0730,000
$9.38-1.11-10.6%$10.24$10.32$9.2890,900
$10.49-0.63-5.7%$11.49$11.65$9.9755,600
$11.12+0.02+0.2%$11.38$11.68$11.1060,900
$11.10-0.39-3.4%$11.41$11.82$10.8594,400
$11.49+0.051+0.4%$11.31$11.62$11.164,200
$11.44+0.339+3.1%$11.05$11.44$11.052,100
$11.10-0.20-1.8%$11.42$11.42$11.002,400
$11.30+0.32+2.9%$11.44$11.55$11.214,800
$10.98-0.49-4.3%$11.36$11.36$10.5342,200
$11.47+0.72+6.7%$10.51$11.47$10.2624,900
$10.75-0.49-4.4%$10.80$10.80$10.673,200
$11.24-0.228-2.0%$11.53$11.94$11.206,900
$11.47+0.668+6.2%$11.30$11.95$10.8117,300
$10.80+0.45+4.3%$10.70$11.17$10.343,876
$10.35+0.06+0.6%$10.59$11.41$10.3020,281
$10.29-0.10-1.0%$10.78$11.15$10.1321,200
$10.39-0.09-0.9%$10.44$11.59$10.1726,900

Splits

2 splits since 2020 · NASDAQ:NVNO · every price before a split is adjusted for it

DayRatioWhat
1-for-35Consolidation
1-for-25Consolidation
Ticker
NASDAQ:NVNO
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All enVVeno Medical Corporation news

enVVeno Medical Corporation on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
17 in the last 12 months · 86 in all · newest Nov 20, 2026 · oldest 2021
Decks
4 decks · latest Jul 14, 2026

Where enVVeno Medical Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:NVNO · Home listing · This pageNASDAQUnited StatesUSD
BOATS:NVNOBOATSUnited StatesUSD
Frankfurt:5HJ0FrankfurtGermanyEUR
Lang & Schwarz:A42085Lang & SchwarzGermanyEUR
LS Exchange:A42085LS ExchangeGermanyEUR

Valuation

Price/book 0.2× against a median of 0.5×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$14.82M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.12

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
enVVeno Medical Corporation · NASDAQ:NVNOUS$3.65M−US$14.82Mn/an/an/a0.2×n/a0.0×1.12
Regentis Biomaterials Ltd. · AMEX:RGNTUS$5.05M−US$3.90Mn/an/an/a0.7×n/a0.0×2.00
SeaStar Medical Holding Corporation · NASDAQ:ICUUS$4.97MUS$981,429n/a0.5×n/a10.6×−678.2%0.0×1.44
WORK Medical Technology Group LTD · NASDAQ:WOKUS$4.84MUS$8.21Mn/a0.8×n/a0.2×−10.9%0.2×2.76
Kelyniam Global, Inc. · OTC:KLYGUS$4.56MUS$4.84Mn/a1.4×31.9×6.6×−6.0%0.6×1.15
Meihua International Medical Technologies Co., Ltd. · OTC:MHUAFUS$4.53M−US$1.63M0.7×−0.0×−0.2×0.0×11.0%0.1×0.62
Aurora Spine Corp. · TSXV:ASGUS$4.36MUS$6.91Mn/a0.4×45.6×1.5×−7.0%1.0×-0.13
IceCure Medical Ltd. · NASDAQ:ICCMUS$3.71M−US$3.80Mn/a−1.0×n/a0.4×−439.7%0.1×1.98
Spineway SA · EURONEXT:ALSPWUS$3.63MUS$1.46Mn/a0.1×n/a0.1×−18.0%0.1×n/a
Baird Medical Investment Holdings Ltd · NASDAQ:BDMDUS$2.88MUS$16.81Mn/a0.8×n/a0.1×−121.0%0.4×-0.13
ScandiDos AB · OMXSTO:SDOSUS$2.84MUS$1.51Mn/a0.3×n/a0.6×−16.4%0.1×n/a
Median of the othersUS$4.45MUS$1.49M0.7×0.4×31.9×0.5×−16.4%0.1×1.30

Forecasts

1 strong buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
30.00 USD · Analysts' mean
EPS, year to Dec 2026
-16.19 · 1 analyst

Team and board

Officers

OfficerRole
Robert BermanChief Executive Officer and Director
Jennifer BrightChief Financial Officer
Avi SharmaSenior Vice President, Clinical, Regulatory and Quality
Hamed AlaviSenior Vice President and Chief Technology Officer
Marc GlickmanSenior Vice President and Chief Medical Officer
Sandy PriettoVice President, Marketing

Board

DirectorRole
Francis DuhayDirector
Matthew JenusaitisDirector
Robert BermanChief Executive Officer and Director
Robert GrayDirector
Sanjay ShrivastavaDirector

Events

QuarterResultsShare move
Q3 2026Oct 29, 2026 · After close−4.1%
Q2 2026Jul 30, 2026 · After close−0.2%
Q1 2026May 6, 2026 · After close+1.5%
Q4 2025Feb 26, 2026−3.4%
Q3 2025Nov 28, 2025+17.1%
Q2 2025Jul 31, 2025 · After close+5.6%
Q1 2025May 6, 2025 · After close+8.0%
Q4 2024Feb 28, 2025 · Before open−9.9%
Q3 2024Oct 31, 2024 · Before open+1.8%
Q2 2024Jul 31, 2024 · After close−0.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close−2.5%
Q4 2023Feb 29, 2024 · After close+3.9%
Q3 2023Oct 26, 2023 · Before open−2.5%
Q2 2023Jul 31, 2023 · After close+5.3%
Q1 2023Apr 28, 2023 · After close−1.9%
Q4 2022Mar 2, 2023 · After close−2.2%
Q3 2022Oct 27, 2022 · After close+1.3%
Q2 2022Aug 3, 2022 · After close+8.5%
Q1 2022Apr 29, 2022 · After close+2.0%
Q4 2021Mar 28, 2022 · Before open+26.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (July 2026)Investor deck25 slidesJul 14, 2026
VEITH Symposium 2024Conference65 slidesNovember 2024
Hancock Jaffe Laboratories — 10th Indonesian Vascular Conference (October 2019)Conference14 slidesOct 25, 2019
Hancock Jaffe Laboratories — Technical Presentation (July 2019)Technical23 slidesJul 26, 2019

Open Decks

IPO

Went public as Hancock Jaffe Laboratories, Inc. Final prospectus filed on Jun 1, 2018.

Price range
US$6.00 to US$8.00 a unit
Units offered
1,142,857 units
Offering size
US$6.9 million to US$9.1 million · Units offered times the price range, worked out by 6ix
Underwriters' option
Up to 171,429 more units
Listing
HJLI on the Nasdaq Capital Market · Has applied to list
Underwriter
Network 1 Financial Securities

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 13, 2017
Filed publiclySep 7, 2017
Amended 8 timesNewest May 30, 2018
Shares registered with an exchangeDec 12, 2017
Declared effective by the SECMay 30, 2018
Final prospectus, with the priceJun 1, 2018

Filings

FilingFiled
424B4 · ProspectusJun 1, 2018
S-1MEF · Registration of more shares for the same offeringMay 31, 2018
EFFECT · Notice that a registration is effectiveMay 30, 2018
CERT · Exchange's certificate of listingMay 30, 2018
S-1/A · Registration statement, amendedMay 30, 2018
8-A12B/A · Registration of shares for listing on an exchange, amendedMay 25, 2018
CORRESP · Letter to the SECMay 25, 2018
CORRESP · Letter to the SECMay 25, 2018
S-1/A · Registration statement, amendedMay 22, 2018
S-1/A · Registration statement, amendedMay 14, 2018
All 34 filings
FilingFiled
FWP · Free writing prospectusApr 24, 2018
S-1/A · Registration statement, amendedApr 16, 2018
FWP · Free writing prospectusMar 12, 2018
FWP · Free writing prospectusMar 2, 2018
CORRESP · Letter to the SECFeb 8, 2018
S-1/A · Registration statement, amendedJan 26, 2018
CORRESP · Letter to the SECDec 18, 2017
CORRESP · Letter to the SECDec 18, 2017
CORRESP · Letter to the SECDec 14, 2017
S-1/A · Registration statement, amendedDec 14, 2017
UPLOAD · Letter from the SECDec 13, 2017
8-A12B · Registration of shares for listing on an exchangeDec 12, 2017
CORRESP · Letter to the SECDec 5, 2017
FWP · Free writing prospectusDec 5, 2017
S-1/A · Registration statement, amendedDec 5, 2017
UPLOAD · Letter from the SECNov 17, 2017
FWP · Free writing prospectusNov 8, 2017
S-1/A · Registration statement, amendedNov 6, 2017
CORRESP · Letter to the SECNov 3, 2017
UPLOAD · Letter from the SECOct 4, 2017
S-1 · Registration statementSep 7, 2017
CORRESP · Letter to the SECSep 6, 2017
UPLOAD · Letter from the SECMar 13, 2017
DRS · Draft registration statementFeb 13, 2017

Open IPO · From the cover of the amended prospectus (S-1/A) filed May 22, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue31.2K186.6K422.1K
Cost of revenue419.7K
Gross profit186.6K2.45K
Research and development9.98M12.2M13.6M9.91M5.73M4.25M2.21M1.24M649.7K
Selling, general and administrative10.9M11.6M11.7M15.0M11.2M4.88M4.91M6.48M5.46M
Operating income-20.9M-23.8M-25.2M-24.9M-16.9M-9.14M-7.68M-7.85M-6.10M
Depreciation and amortization136.0K189.0K220.0K212.0K149.0K97.5K123.7K133.4K139.2K
EBITDA-20.8M-23.6M-25.0M-24.7M-16.7M-9.04M-7.55M-7.72M-5.96M
Interest expense305.5K172.8K
Income before tax-19.5M-21.8M
Net income-19.5M-21.8M-23.5M-24.7M-16.5M-9.14M-7.63M-13.0M-7.79M
Earnings per share, basic-33.06-44.53-1.91-2.20-1.90-7.54-12.10-1.75-1.35
Earnings per share, diluted-33.06-44.53-1.91-2.20-1.90-7.54-12.10-1.75-1.35

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.06M1.75M3.62M4.55M54.7M9.33M1.31M2.74M77.7K
Short-term investments25.1M41.4M42.8M34.5M
Receivables32.0K35.2K
Current assets28.8M43.7M46.9M39.4M55.0M9.57M1.42M2.84M170.4K
Property, plant and equipment51.0K182.0K334.0K521.0K618.0K399.0K344.0K26.2K23.8K
Total assets29.6M45.0M48.6M41.7M57.7M10.5M3.43M3.56M2.21M
Accounts payable358.0K1.01M1.22M560.0K1.39M1.22M1.08M1.45M
Current liabilities2.12M2.10M1.37M1.53M1.58M3.19M1.88M1.52M
Total liabilities2.43M2.79M2.44M2.93M3.29M3.44M2.44M1.52M8.17M
Shareholders' equity27.1M42.2M46.2M38.7M54.4M7.10M989.9K2.04M-11.1M
Shares outstanding656.0K501.0K13.3M9.47M9.47M2.54M717.3K11.7M6.13M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-15.6M-16.8M-18.9M-15.6M-11.8M-7.68M-5.90M-6.36M-4.20M
Capital spending-5.00K-37.0K-33.0K-115.0K-368.0K-180.3K-363.9K-12.4K-10.9K
Free cash flow-15.6M-16.9M-18.9M-15.7M-12.2M-7.86M-6.26M-6.37M-4.21M
Cash from investing15.9M1.33M-7.87M-34.6M-368.0K-180.3K-363.9K-12.4K165.3K
Cash from financing1.02M13.6M25.8M57.6M15.1M5.64M9.03M4.06M
Change in cash1.31M-1.87M-935.0K-50.2M45.4M7.22M-623.4K2.66M21.2K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementOct 29, 2026Meeting noticeSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 15, 2026Big-stake noticeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
S-3 · Registration statementAug 21, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportJul 14, 2026Current reportSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
144 · Notice of proposed saleJun 11, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportApr 29, 2026ResultsSEC
S-8 · Registration statement for employee plansMar 26, 2026Offer documentSEC
10-K · Annual reportMar 26, 2026Annual reportSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
SCHEDULE 13D · Big-stake noticeFeb 20, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeFeb 20, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 10, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 10, 2026Big-stake noticeSEC
8-K · Current reportFeb 4, 2026ResultsSEC
8-K · Current reportJan 20, 2026Current reportSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
8-K · Current reportDec 12, 2025Meeting outcomeSEC
DEFR14ADec 2, 2025Meeting noticeSEC
8-K · Current reportNov 20, 2025Current reportSEC
PRER14ANov 19, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 19, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
8-K · Current reportNov 13, 2025Current reportSEC
8-K · Current reportOct 30, 2025Material contractSEC
424B5 · ProspectusOct 30, 2025Offer documentSEC
DEFA14A · Additional proxy materialOct 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementOct 30, 2025Meeting noticeSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
8-K · Current reportOct 10, 2025Current reportSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
144 · Notice of proposed saleSep 15, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeSep 9, 2025Big-stake noticeSEC
8-K · Current reportAug 20, 2025Current reportSEC
10-Q · Quarterly reportJul 31, 2025Quarterly reportSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 20, 2025Insider tradeSEC
8-K · Current reportMay 20, 2025Management or board changeSEC
10-Q · Quarterly reportApr 30, 2025Quarterly reportSEC
8-K · Current reportApr 21, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveMar 17, 2025Other filingsSEC
CORRESP · Letter to the SECMar 14, 2025Other filingsSEC
S-8 · Registration statement for employee plansMar 12, 2025Offer documentSEC
S-3/A · Registration statement, amendedMar 12, 2025Offer documentSEC
UPLOAD · Letter from the SECMar 10, 2025Other filingsSEC
S-3 · Registration statementFeb 28, 2025Offer documentSEC
10-K/A · Annual report, amendedFeb 28, 2025Annual reportSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
8-K · Current reportDec 23, 2024Meeting outcomeSEC
4 · Change in ownershipDec 23, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 19, 2024Insider tradeSEC
DEF 14A · Proxy statementNov 19, 2024Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportOct 30, 2024Quarterly reportSEC
8-K · Current reportSep 30, 2024Material contractSEC
424B5 · ProspectusSep 30, 2024Offer documentSEC
FWP · Free writing prospectusSep 26, 2024Offer documentSEC
424B5 · ProspectusSep 26, 2024Offer documentSEC
10-Q · Quarterly reportJul 31, 2024Quarterly reportSEC
S-8 · Registration statement for employee plansMay 9, 2024Offer documentSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportApr 24, 2024Current reportSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
8-K · Current reportMar 6, 2024Current reportSEC
10-K · Annual reportFeb 29, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 23, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
8-K · Current reportDec 7, 2023Meeting outcomeSEC
8-K · Current reportNov 16, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveNov 6, 2023Other filingsSEC
DEF 14A · Proxy statementNov 3, 2023Meeting noticeSEC
CORRESP · Letter to the SECNov 1, 2023Other filingsSEC
UPLOAD · Letter from the SECOct 31, 2023Other filingsSEC
S-3 · Registration statementOct 26, 2023Offer documentSEC
10-Q · Quarterly reportOct 25, 2023Quarterly reportSEC
8-K · Current reportOct 12, 2023Material contractSEC
EFFECT · Notice that a registration is effectiveAug 24, 2023Other filingsSEC
CORRESP · Letter to the SECAug 21, 2023Other filingsSEC
S-3/A · Registration statement, amendedAug 14, 2023Offer documentSEC
UPLOAD · Letter from the SECAug 7, 2023Other filingsSEC
S-3 · Registration statementJul 31, 2023Offer documentSEC
10-Q · Quarterly reportJul 31, 2023Quarterly reportSEC
25-NSEMay 26, 2023Other filingsSEC
424B3 · ProspectusMay 5, 2023Offer documentSEC
10-Q · Quarterly reportApr 28, 2023Quarterly reportSEC
10-K · Annual reportMar 2, 2023Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
3 · Initial statement of ownershipJan 31, 2023Insider tradeSEC
8-K · Current reportDec 6, 2022Meeting outcomeSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
DEF 14A · Proxy statementNov 1, 2022Meeting noticeSEC
10-Q · Quarterly reportOct 27, 2022Quarterly reportSEC
4 · Change in ownershipSep 16, 2022Insider tradeSEC
4 · Change in ownershipSep 16, 2022Insider tradeSEC
4 · Change in ownershipAug 18, 2022Insider tradeSEC
10-Q · Quarterly reportAug 3, 2022Quarterly reportSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
UPLOAD · Letter from the SECMay 16, 2022Other filingsSEC
10-Q/A · Quarterly report, amendedMay 11, 2022Quarterly reportSEC
10-K/A · Annual report, amendedMay 11, 2022Annual reportSEC
CORRESP · Letter to the SECMay 11, 2022Other filingsSEC
UPLOAD · Letter from the SECMay 6, 2022Other filingsSEC
10-Q · Quarterly reportApr 29, 2022Quarterly reportSEC
S-8 · Registration statement for employee plansApr 18, 2022Offer documentSEC
10-K · Annual reportMar 28, 2022Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 19, 2022Big-stake noticeSEC
8-K/A · Current report, amendedDec 3, 2021Meeting outcomeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
8-K · Current reportDec 1, 2021Meeting outcomeSEC
4 · Change in ownershipNov 19, 2021Insider tradeSEC
4 · Change in ownershipNov 18, 2021Insider tradeSEC
4 · Change in ownershipNov 18, 2021Insider tradeSEC
10-Q · Quarterly reportNov 10, 2021Quarterly reportSEC
DEF 14A · Proxy statementNov 1, 2021Meeting noticeSEC
8-K · Current reportOct 1, 2021Current reportSEC
8-K · Current reportSep 22, 2021Current reportSEC
SC 13G · Big-stake noticeSep 17, 2021Big-stake noticeSEC
4 · Change in ownershipSep 15, 2021Insider tradeSEC
4 · Change in ownershipSep 15, 2021Insider tradeSEC
8-K · Current reportSep 8, 2021Material contractSEC
424B5 · ProspectusSep 8, 2021Offer documentSEC
4 · Change in ownershipAug 27, 2021Insider tradeSEC
8-K · Current reportAug 12, 2021Material contractSEC
424B5 · ProspectusAug 12, 2021Offer documentSEC
10-Q · Quarterly reportAug 10, 2021Quarterly reportSEC
424B3 · ProspectusAug 6, 2021Offer documentSEC
4 · Change in ownershipJun 21, 2021Insider tradeSEC
S-8 · Registration statement for employee plansMay 26, 2021Offer documentSEC
4 · Change in ownershipMay 25, 2021Insider tradeSEC
4 · Change in ownershipMay 19, 2021Insider tradeSEC
4 · Change in ownershipMay 19, 2021Insider tradeSEC
10-Q · Quarterly reportMay 12, 2021Quarterly reportSEC
EFFECT · Notice that a registration is effectiveMay 7, 2021Other filingsSEC
POS AM · Amendment to an effective registrationApr 30, 2021Offer documentSEC
10-K · Annual reportMar 31, 2021Annual reportSEC
8-K · Current reportFeb 24, 2021Management or board changeSEC
4 · Change in ownershipFeb 23, 2021Insider tradeSEC
3 · Initial statement of ownershipFeb 23, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
4 · Change in ownershipFeb 22, 2021Insider tradeSEC
SC 13G · Big-stake noticeFeb 19, 2021Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 17, 2021Big-stake noticeSEC
8-K · Current reportFeb 12, 2021Material contractSEC
424B4 · ProspectusFeb 9, 2021Offer documentSEC

This page holds 200 of 416 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from enVVeno Medical Corporation’s releases · as of Oct 27, 2026

Common shares
694,826
Fully diluted
694,826

Fully diluted

LineSharesAs of
Common shares694,826Oct 27, 2026

Share count over time

CountShares
Oct 27, 2026694,826

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Kingdon Capital Management, L.L.C.36,1665.2%US$282KSep 30, 2026
CM Management, LLC17,1422.5%US$134KSep 30, 2026
Citadel15,3142.2%US$130KSep 30, 2026
Vanguard8,5481.2%US$72,316Sep 30, 2026
JPMorgan5,2190.75%US$44,048Sep 30, 2026
UBS1,9650.28%US$15,327Sep 30, 2026
Westside Investment Management, Inc.1,5250.22%US$11,895Sep 30, 2026
Tower Research Capital LLC (TRC)5800.08%US$4,524Sep 30, 2026
Mirae Asset Global Investments Co., Ltd.5390.08%US$4,204Sep 30, 2026
BlackRock4140.06%US$3,229Sep 30, 2026
All 15 holders
HolderSharesOf the companyValueAs of
Morgan Stanley59<0.01%US$460Sep 30, 2026
Wells Fargo57<0.01%US$445Sep 30, 2026
Osaic Holdings, Inc.7<0.01%US$60Sep 30, 2026
Group One Trading LLC2<0.01%US$17Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%US$8Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund6,2870.90%US$67,397Jun 30, 2026
Fidelity Extended Market Index Fund5,9950.86%US$67,923May 31, 2026
Fidelity Total Market Index Fund8410.12%US$9,529May 31, 2026
Fidelity Series Total Market Index Fund8050.12%US$9,121May 31, 2026
Fidelity Nasdaq Composite Index Fund5850.08%US$6,628May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Duhay Francis
Director
Sale11USD 11.21US$123Sep 11, 2026
Duhay Francis
Director
Sale140USD 10.31US$1,443Jun 11, 2026

Big stakes

StakeStakeSharesDateFiling
Kingdon Capital Management, L.L.C.5.50%36,166Mar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Steven Girgenti
Other companies: bioAffinity Technologies, Inc. (Executive Chairman, Director · Aug 29, 2022 – Jan 10, 2025 · Past); Vycor Medical Inc. (Director · Mar 11, 2014 – Apr 1, 2021 · Past)
Director · May 30, 2018 – May 30, 2018 · Past
Robert Berman
Other companies: Anixa Biosciences, Inc. (President & CEO, Director · Jul 1, 2013 – Jun 2, 2017 · Past)
Chief Executive Officer and Director · Since at least May 30, 2018
William R Abbott
Other companies: Astrana Health Inc. (VP Finance & Corp. Controller · Sep 20, 2015 – Sep 20, 2015 · Past)
See Remarks. · May 30, 2018 – May 30, 2018 · Past
Avi SharmaSenior Vice President, Clinical, Regulatory and Quality · Since at least Nov 5, 2026
Craig GlynnChief Financial Officer · Apr 6, 2020 – Dec 5, 2023 · Past
Francis DuhayDirector · Since at least Aug 16, 2022
Hamed AlaviChief Technology Officer · Since at least Dec 16, 2025
Jennifer BrightChief Financial Officer · Since at least May 19, 2025
Marc GlickmanSenior Vice President and Chief Medical Officer · Since at least May 30, 2018
Matthew JenusaitisDirector · Since at least Oct 21, 2020
All 15 people
PersonSeat
Robert A RankinChief Financial Officer · Jul 16, 2018 – Jul 16, 2018 · Past
Robert GrayDirector · Since at least Dec 5, 2023
Sandy PriettoVice President, Marketing · Since at least Nov 4, 2026
Sanjay ShrivastavaDirector · Since at least Oct 2, 2018
Susan MontoyaSee Remarks · May 30, 2018 – May 30, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about enVVeno Medical Corporation.